Patrick Ogle Takes 15.9% Stake in cbdMD, Gains Board Nomination Right

What happened

Patrick Ogle, through Akretive Holdings, acquired 2,229,805 cbdMD shares on October 30, 2026, giving him a 15.9% stake. An asset purchase agreement also gives the company’s Nominating and Corporate Governance Committee the right to consider a director nominee from Akretive, but does not guarantee a board seat.

Confirmed

Global impact / market context

A 15.9% holding gives Ogle a substantial ownership position, while the nomination right creates a route to raise his views in a committee discussion. If the committee considers a nominee, governance decisions could reflect his input, but the agreement does not ensure an appointment or influence over company operations.

Analyst inference

The agreement also involved a senior secured promissory note, which means a loan backed by security, alongside the shares. This links the transaction to both ownership and lending claims; the supplied article gives no details on the note’s value, terms, or any resulting change to cbdMD’s cash available.

Confirmed

What to watch

1. Whether cbdMD’s Nominating and Corporate Governance Committee considers an Akretive nominee, and whether it ultimately appoints that person to the board, remain unresolved. Confirmed
2. Further details on the senior secured promissory note, including its amount and repayment terms, would clarify the scale of Akretive’s lending claim alongside its shareholding. Analyst inference
3. Any later disclosure about Ogle’s share ownership or voting and selling decisions could show whether his 15.9% position changes, potentially altering his influence as a shareholder. Analyst inference

Evidence

• Original source link unavailable